Capital Bank & Trust CO Hutchmed (China) LTD Transaction History

Capital Bank & Trust CO

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$35.66 - $42.94 $9.28 Million - $11.2 Million	-260,253 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$23.7 - $39.27 $268,047 - $444,143	-11,310 Reduced 4.16%	260,253 $10.2 Million
Q1 2021 May 14, 2021	SELL	$27.01 - $36.8 $115,683 - $157,614	-4,283 Reduced 1.55%	271,563 $7.67 Million
Q4 2020 Feb 16, 2021	BUY	$27.51 - $34.36 $422,856 - $528,147	15,371 Added 5.9%	275,846 $8.83 Million
Q3 2020 Nov 13, 2020	SELL	$25.8 - $34.61 $50,851 - $68,216	-1,971 Reduced 0.75%	260,475 $8.41 Million
Q2 2020 Aug 14, 2020	SELL	$17.65 - $28.05 $68,534 - $108,918	-3,883 Reduced 1.46%	262,446 $7.24 Million
Q1 2020 May 15, 2020	SELL	$15.19 - $29.51 $148,208 - $287,929	-9,757 Reduced 3.53%	266,329 $4.75 Million
Q4 2019 Feb 18, 2020	SELL	$17.17 - $25.95 $128,088 - $193,587	-7,460 Reduced 2.63%	276,086 $6.92 Million
Q3 2019 Nov 14, 2019	SELL	$17.84 - $22.69 $533,986 - $679,157	-29,932 Reduced 9.55%	283,546 $5.06 Million
Q2 2019 Aug 14, 2019	BUY	$22.0 - $31.78 $980,628 - $1.42 Million	44,574 Added 16.58%	313,478 $7.75 Million
Q1 2019 May 15, 2019	BUY	$21.27 - $30.58 $5.72 Million - $8.22 Million	268,904 New	268,904 $8.19 Million

6.88M

6.2K

1.1K

Ticker HCM
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 172,955,008
Market Cap $2.57B
Description
HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...

Get notified when there are updates to the investment portfolio of Capital Bank & Trust CO, based on Form 13F filings with the SEC.

Stay updated on Capital Bank & Trust CO with notifications on news.